医学临床研究
  2025年7月8日 星期二           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2021, Vol. 38 Issue (2): 175-178    DOI: 10.3969/j.issn.1671-7171.2021.02.005
  论著 本期目录 | 过刊浏览 | 高级检索 |
BIS指导给药在重型颅脑损伤患者麻醉诱导阶段的应用
杜振杰1, 罗辉宇2**, 徐阳2, 徐姝珺1, 左琴蓉1, 李清3
1.锦州医科大学襄阳市第一人民医院研究生培养基地,湖北 襄阳 441000;
2.湖北医药学院附属襄阳市第一人民医院麻醉科,湖北 襄阳 441000;
3.湖北医药学院附属十堰市太和医院麻醉科,湖北 十堰 442000
Application of BIS-guided Administration in Anesthesia Induction Stage of Patients with Severe Traumatic Brain Injury
DU Zhen-jie, LUO Hui-yu, XU Yang, et al
Postgraduate Training Base of First People's Hospital of Xiangyang City,Jinzhou Medical University Xiangyang 441000
全文: PDF (1186 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】 探讨在重型颅脑损伤(severe traumatic brain injury,STBI)患者的麻醉诱导阶段,脑电双频谱指数(bispectral index,BIS)指导下给药的应用价值。【方法】 将52例STBI拟行手术治疗的患者随机分为观察组和对照组,每组26例。观察组依据BIS值给药诱导,静脉缓慢推注丙泊酚,当BIS达到预定值(40~60)时,立即推注舒芬太尼0.4 μg/kg、罗库溴铵0.6 mg/kg,肌松满意后行经口明视下气管插管;对照组依据临床经验及患者体重推注丙泊酚,其余给药方式及插管方式与观察组相同。分别在入室麻醉诱导前(T0)、气管插管前即刻(T1)、气管插管后1 min(T2)、气管插管后5 min(T3)、气管插管后10 min(T4),记录两组患者的平均动脉压(MAP)、心率(HR)、脑电双频谱指数(BIS)。同时在T0、T1、T3等时间点抽取患者静脉血,测定其体内血浆皮质醇(plasma cortisol,COR)水平。并记录诱导阶段丙泊酚的用量。【结果】 与T0相比,给药后两组患者MAP、HR、BIS值均下降,气管插管后MAP 、HR、BIS值均升高,且在T2达高峰(P<0.05);与观察组相比,对照组MAP、BIS值波动幅度更大,两组间比较的差异有统计学意义(P<0.05)。两组患者T0时间点COR水平均高于正常值水平,气管插管后两组患者COR水平均升高,但两组间比较的差异无统计学意义(P>0.05)。观察组麻醉诱导阶段丙泊酚的用量为(1.1±0.3)mg/kg,明显少于对照组的(1.7±0.2)mg/kg,两组间比较的差异有统计学意义(P<0.05)。【结论】 在重型颅脑损伤患者麻醉诱导阶段,BIS指导下给药在保证了麻醉深度的同时,可减少丙泊酚的用量,避免了低BIS值现象的发生,使血流动力学更加平稳,同时也可抑制气管插管引起的应激反应,明显优于常规经验给药,具有良好的应用价值。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 颅脑损伤脑电描记术麻醉二异丙酚应激,生理学    
Abstract【Objective】 To investigate the application value of bispectral index (BIS) in the anesthesia induction stage of patients with severe traumatic brain injury (STBI). 【Methods】 Fifty-two patients with severe traumatic brain injury (STBI) were randomly divided into the observation group (group N,n=26) and the control group (group C,n=26). In group N, propofol was slowly injected according to the BIS value. In brief, when the BIS value reached the predetermined value (40~60), sufentanil 0.4μg/kg and rocuronium 0.6mg/kg were injected immediately. Then tracheal intubation was performed when muscle relaxation was satisfactory. In group C, propofol was slowly injected according to the doctor's clinical experience and patient's weight. The other administrations and intubation methods were the same as those of group N. Mean arterial pressure (MAP), heart rate (HR) and BIS value were recorded before induction (T0), before tracheal intubation (T1), and 1 (T2), 5 (T3), 10 (T4) minutes afterwards. Venous blood samples were collected to determine the plasma cortisol (COR) level at T0, T1 and T3. Besides, the dosage of propofol used during induction was recorded. 【Results】 Compared to T0, the MAP, HR and BIS value in both groups were significantly decreased after induction and increased after tracheal intubation(P<0.05). Compared with Group N, MAP and BIS value had a significantly wider fluctuation range in Group C(P<0.05). At the point of T0, COR levels in both groups were higher than the normal level. After tracheal intubation, COR levels in both groups were increased, but there was no significant difference between the two groups(P>0.05). The dosage of propofol in group N was (1.1±0.3)mg/kg, which was significantly lower than that in group C (1.7±0.2)mg/kg; the difference was statistically significant (P<0.05). 【Conclusions】 In the anesthesia induction stage of patients with severe traumatic brain injury, administration under the guidance of BIS can not only ensure the depth of anesthesia, but also inhibit the stress reaction caused by endotracheal intubation. It can also reduce the dosage of propofol used, avoid the occurrence of low BIS value, and make the hemodynamics more stable, which is obviously better than the normal administration.
Key wordsCraniocerebral Trauma    Electroencephalography    Anesthesia    Propofol    Stress, Physiological
收稿日期: 2020-11-27     
中图分类号:  R651.15  
基金资助:湖北省自然科学基金资助项目(2019CFB411)
通讯作者: **E-mail:luouu543@163.com   
引用本文:   
杜振杰, 罗辉宇, 徐阳, 徐姝珺, 左琴蓉, 李清. BIS指导给药在重型颅脑损伤患者麻醉诱导阶段的应用[J]. 医学临床研究, 2021, 38(2): 175-178.
DU Zhen-jie, LUO Hui-yu, XU Yang, et al. Application of BIS-guided Administration in Anesthesia Induction Stage of Patients with Severe Traumatic Brain Injury. JOURNAL OF CLINICAL RESEARCH, 2021, 38(2): 175-178.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2021.02.005     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2021/V38/I2/175
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn